|Articles|November 19, 2015
Michael J. Mauro on Questions From Patients With CML
Author(s)Michael J. Mauro
Michael J. Mauro, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).
Advertisement
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, provides an overview of some of the questions he hears from patients with chronic myeloid leukemia (CML).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Updates Safety Warnings for Common Chemotherapy Drugs
2
FDA Removes Use Limitation for Yescarta in Primary CNS Lymphoma
3
Real-World Data with Amtagvi Show High Response Rates in Advanced Melanoma
4
Chemo Brain is Real: My Experience with a Clinical Study and What It Can Teach Us
5